{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:07:04Z","timestamp":1788476824899,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cpt.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T09:58:09Z","timestamp":1743155889000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clotrimazole as a new frontier: Drug repurposing and its efficacy in cancer therapy"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7775-0977","authenticated-orcid":false,"given":"Shubham C.","family":"Karpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5044-233X","authenticated-orcid":false,"given":"Sukhen","family":"Majhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1197-3428","authenticated-orcid":false,"given":"Jaipal","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1489-8144","authenticated-orcid":false,"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Chander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupkumar R.","family":"Anvikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-7784","authenticated-orcid":false,"given":"Harit","family":"Kasana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2025.03.004_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cpt.2025.03.004_bib2","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3390\/cancers15082256","article-title":"A recent review on cancer nanomedicine","volume":"15","author":"Giri","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cpt.2025.03.004_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jare.2022.08.018","article-title":"Repurposing antifungal drugs for cancer therapy","volume":"48","author":"Weng","year":"2023","journal-title":"J Adv Res"},{"key":"10.1016\/j.cpt.2025.03.004_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2019.12.012","article-title":"Drug repurposing for cancer therapy, easier said than done","volume":"68","author":"Gonzalez-Fierro","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.cpt.2025.03.004_bib5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2165\/00003495-197509060-00003","article-title":"Clotrimazole: a review of its antifungal activity and therapeutic efficacy","volume":"9","author":"Sawyer","year":"1975","journal-title":"Drugs"},{"key":"10.1016\/j.cpt.2025.03.004_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/jam.12554","article-title":"Clotrimazole as a pharmaceutical: past, present and future","volume":"117","author":"Crowley","year":"2014","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.cpt.2025.03.004_bib7","first-page":"722","article-title":"Clotrimazole as a cancer drug: a short review","volume":"4","author":"Kadavakollu","year":"2014","journal-title":"Med Chem (Los Angeles)"},{"key":"10.1016\/j.cpt.2025.03.004_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166263","article-title":"Clotrimazole presents anticancer properties against a mouse melanoma model acting as a PI3K inhibitor and inducing repolarization of tumor-associated macrophages","volume":"1867","author":"Ochioni","year":"2021","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"key":"10.1016\/j.cpt.2025.03.004_bib9","article-title":"The in vitro and in vivo antitumor effects of clotrimazole on oral squamous cell carcinoma","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.03.004_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10555-020-09885-8","article-title":"CDK7 inhibitors as anticancer drugs","volume":"39","author":"Sava","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.cpt.2025.03.004_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S0099-5428(08)60265-8","article-title":"Clotrimazole","author":"Hoogerheide","year":"1982"},{"key":"10.1016\/j.cpt.2025.03.004_bib12","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 2812, Clotrimazole. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Clotrimazole. [Accessed March 9, 2025]."},{"key":"10.1016\/j.cpt.2025.03.004_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.chemosphere.2013.01.050","article-title":"Clotrimazole, but not dexamethasone, is a potent in vitro inhibitor of cytochrome P450 isoforms CYP1A and CYP3A in rainbow trout","volume":"92","author":"Burkina","year":"2013","journal-title":"Chemosphere"},{"key":"10.1016\/j.cpt.2025.03.004_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/dmd.30.3.314","article-title":"Inhibition of cytochromes P450 by antifungal imidazole derivatives","volume":"30","author":"Zhang","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cpt.2025.03.004_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tox.2006.08.007","article-title":"Comparison of lanosterol-14\u03b1-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles","volume":"228","author":"Tr\u00f6sken","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.cpt.2025.03.004_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104240","article-title":"History of the development of antifungal azoles: a review on structures, SAR, and mechanism of action","volume":"104","author":"Shafiei","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.cpt.2025.03.004_bib17","first-page":"5","article-title":"Clotrimazole: summary report","author":"Mattingly","year":"2021","journal-title":"Silver Spring: Food and Drug Administration"},{"key":"10.1016\/j.cpt.2025.03.004_bib18","unstructured":"Khatter NJ, Khan MA. Clotrimazole. In: StatPearls. Treasure Island (FL): StatPearls Publishing; Clotrimazole - StatPearls - NCBI Bookshelf. [Accessed January 19, 2025]."},{"key":"10.1016\/j.cpt.2025.03.004_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1021\/acs.jced.2c00680","article-title":"Solubility and thermodynamic properties of clotrimazole in 16 organic solvents at temperature of 283.15 to 323.15 K","volume":"68","author":"Ma","year":"2023","journal-title":"J Chem Eng Data"},{"key":"10.1016\/j.cpt.2025.03.004_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.cpt.2025.03.004_bib21","first-page":"204","article-title":"A descriptive review on pharmacokinetics and pharmacodynamics profile of an antifungal agent: clotrimazole","volume":"9","author":"Tushir","year":"2022","journal-title":"Eur J Pharm Med Res"},{"key":"10.1016\/j.cpt.2025.03.004_bib22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0002-9378(85)80006-5","article-title":"Pharmacokinetic fundamentals of vaginal treatment with clotrimazole","volume":"152","author":"Ritter","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cpt.2025.03.004_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02977701","article-title":"Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with \u03b2-cyclodextrin","volume":"30","author":"Prabagar","year":"2007","journal-title":"Arch Pharm Res (Seoul)"},{"key":"10.1016\/j.cpt.2025.03.004_bib24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.ftd.0000151186.91464.7c","article-title":"Concomitant clotrimazole therapy more than doubles the relative oral bioavailability of tacrolimus","volume":"27","author":"Vasquez","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cpt.2025.03.004_bib25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2125.2009.03559.x","article-title":"Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam","volume":"69","author":"Shord","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cpt.2025.03.004_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00228-019-02770-6","article-title":"Drug interactions between tacrolimus and clotrimazole troche: a data mining approach followed by a pharmacokinetic study","volume":"76","author":"Uno","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cpt.2025.03.004_bib27","doi-asserted-by":"crossref","first-page":"13767","DOI":"10.1021\/acs.langmuir.1c02590","article-title":"Microemulsified gel formulations for topical delivery of clotrimazole: structural and in vitro evaluation","volume":"37","author":"Yasir Siddique","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.cpt.2025.03.004_bib28","article-title":"A review on drug delivery system for tumor therapy","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpt.2025.03.004_bib29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/cncr.28501","article-title":"Targeting glucose metabolism in patients with cancer","volume":"120","author":"Elf","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.cpt.2025.03.004_bib30","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.3390\/cancers13164184","article-title":"Glucose transporters as a target for anticancer therapy","volume":"13","author":"Pliszka","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cpt.2025.03.004_bib31","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3390\/cancers12082252","article-title":"Targeting glucose metabolism to overcome resistance to anticancer chemotherapy in breast cancer","volume":"12","author":"Varghese","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cpt.2025.03.004_bib32","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.3390\/cancers14194568","article-title":"Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cpt.2025.03.004_bib33","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3390\/cancers12102819","article-title":"The Warburg effect 97 years after its discovery","volume":"12","author":"Pascale","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cpt.2025.03.004_bib34","article-title":"The mechanism of Warburg effect-induced chemoresistance in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.cpt.2025.03.004_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-030-65768-0_1","article-title":"Glucose metabolism in cancer: the Warburg effect and beyond","volume":"1311","author":"Bose","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cpt.2025.03.004_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102065","article-title":"Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions","volume":"46","author":"Ying","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.cpt.2025.03.004_bib37","first-page":"141","article-title":"Lactate and acidity in the cancer microenvironment","volume":"4","author":"Parks","year":"2020","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/j.cpt.2025.03.004_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030462","article-title":"Clotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis","volume":"7","author":"Furtado","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.03.004_bib39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ymgme.2011.04.003","article-title":"Clotrimazole disrupts glycolysis in human breast cancer without affecting non-tumoral tissues","volume":"103","author":"Coelho","year":"2011","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.cpt.2025.03.004_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1096-7192(02)00046-X","article-title":"Detachment of glycolytic enzymes from cytoskeleton of Lewis lung carcinoma and colon adenocarcinoma cells induced by clotrimazole and its correlation to cell viability and morphology","volume":"76","author":"Penso","year":"2002","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.cpt.2025.03.004_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001852","article-title":"Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels","volume":"3","author":"Chiara","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.03.004_bib42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/CAD.0b013e32833e8022","article-title":"Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro","volume":"21","author":"Liu","year":"2010","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.cpt.2025.03.004_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(97)01507-0","article-title":"Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells","volume":"342","author":"Penso","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cpt.2025.03.004_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.21448\/ijsm.714310","article-title":"Imidazole antifungals: a review of their action mechanisms on cancerous cells","volume":"7","author":"Kavakc\u0131o\u011flu Yard\u0131mc\u0131","year":"2020","journal-title":"Int J Second Metabolite"},{"key":"10.1016\/j.cpt.2025.03.004_bib45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ymgme.2004.11.012","article-title":"Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes","volume":"84","author":"Meira","year":"2005","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.cpt.2025.03.004_bib46","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s43018-023-00556-5","article-title":"GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity","volume":"4","author":"Watson","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.cpt.2025.03.004_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130555","article-title":"Nanomicellar formulation of clotrimazole improves its antitumor action toward human breast cancer cells","volume":"10","author":"Marcondes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2025.03.004_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.msec.2018.03.030","article-title":"Self-assembled nanomicelles of amphiphilic clotrimazole glycyl-glycine analogue augmented drug delivery, apoptosis and restrained melanoma tumour progression","volume":"89","author":"Kaur","year":"2018","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.cpt.2025.03.004_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216285","article-title":"Ik channel-independent effects of clotrimazole and senicapoc on cancer cells viability and migration","volume":"24","author":"Zuccolini","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.03.004_bib50","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1124\/dmd.123.001464","article-title":"Differential effects of clotrimazole on X-ray crystal structures of human cytochromes P450 3A5 and 3A4","volume":"51","author":"Hsu","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cpt.2025.03.004_bib51","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/ijms24032606","article-title":"Modulating glycolysis to improve cancer therapy","volume":"24","author":"Chelakkot","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.03.004_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbrc.2018.10.053","article-title":"Clotrimazole inhibits the Wnt\/\u03b2-catenin pathway by activating two eIF2\u03b1 kinases: the heme-regulated translational inhibitor and the double-stranded RNA-induced protein kinase","volume":"506","author":"Yonezawa","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cpt.2025.03.004_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111354","article-title":"Clotrimazole ameliorates chronic mild stress-induced depressive-like behavior in rats; crosstalk between the HPA, NLRP3 inflammasome, and Wnt\/\u03b2-catenin pathways","volume":"127","author":"Fawzi","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.cpt.2025.03.004_bib54","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/jof7080647","article-title":"Clotrimazole-induced oxidative stress triggers novel yeast Pkc1-independent cell wall integrity MAPK pathway circuitry","volume":"7","author":"Sellers-Moya","year":"2021","journal-title":"J Fungi"},{"key":"10.1016\/j.cpt.2025.03.004_bib55","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2147\/DDDT.S354205","article-title":"Clotrimazole inhibits HCC migration and invasion by modulating the ERK-p65 signaling pathway","volume":"16","author":"Liu","year":"2022","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.cpt.2025.03.004_bib56","first-page":"1602","article-title":"PI3K\/Akt\/mTOR signaling pathway in cancer stem cells: from basic research to sclinical application","volume":"5","author":"Xia","year":"2015","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.cpt.2025.03.004_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1127704","article-title":"Immunomodulation\u2014a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system","volume":"14","author":"Strzelec","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cpt.2025.03.004_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2023.111883","article-title":"Clotrimazole is effective, safe and tolerable for the treatment of endometriosis and functions by downregulating inducible nitric oxide synthase and modulating oxidative stress biomarkers","volume":"564","author":"Machado","year":"2023","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cpt.2025.03.004_bib59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/jpet.108.141887","article-title":"Clotrimazole ameliorates intestinal inflammation and abnormal angiogenesis by inhibiting interleukin-8 expression through a nuclear factor-\u03baB-dependent manner","volume":"327","author":"Thapa","year":"2008","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.cpt.2025.03.004_bib60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41368-020-0084-8","article-title":"Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma","volume":"12","author":"Mei","year":"2020","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.cpt.2025.03.004_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.synres.2017.09.001","article-title":"Combinational effect of Paclitaxel and Clotrimazole on human breast cancer: Proof for synergistic interaction","volume":"5","author":"Sharma","year":"2017","journal-title":"Synergy"},{"key":"10.1016\/j.cpt.2025.03.004_bib62","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4062\/biomolther.2018.042","article-title":"Imidazole antifungal drugs inhibit the cell proliferation and invasion of human breast cancer cells","volume":"26","author":"Bae","year":"2018","journal-title":"Biomol Ther"},{"key":"10.1016\/j.cpt.2025.03.004_bib63","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10565-013-9264-z","article-title":"Analysis of the cytotoxic effects of ruthenium\u2013ketoconazole and ruthenium\u2013clotrimazole complexes on cancer cells","volume":"29","author":"Robles-Escajeda","year":"2013","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.cpt.2025.03.004_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cbi.2015.03.028","article-title":"Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells","volume":"233","author":"Motawi","year":"2015","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.cpt.2025.03.004_bib65","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.sjbs.2021.10.041","article-title":"Novel clotrimazole and Vitis vinifera loaded chitosan nanoparticles: antifungal and wound healing efficiencies","volume":"29","author":"Elshaer","year":"2022","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.cpt.2025.03.004_bib66","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3390\/pharmaceutics13101588","article-title":"Multilayer films based on chitosan\/pectin polyelectrolyte complexes as novel platforms for buccal administration of clotrimazole","volume":"13","author":"Pota\u015b","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cpt.2025.03.004_bib67","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1039\/D2TB02629E","article-title":"Cross-linkable star-hyperbranched unimolecular micelles for the enhancement of the anticancer activity of clotrimazole","volume":"11","author":"Gosecki","year":"2023","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.cpt.2025.03.004_bib68","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s11243-009-9276-y","article-title":"Synthesis, characterization, DNA interaction studies and anticancer activity of platinum\u2013clotrimazole complexes","volume":"34","author":"Navarro","year":"2009","journal-title":"Transit Met Chem"},{"key":"10.1016\/j.cpt.2025.03.004_bib69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jinorgbio.2005.10.013","article-title":"Synthesis and characterization of new palladium\u2013clotrimazole and palladium\u2013chloroquine complexes showing cytotoxicity for tumor cell lines in vitro","volume":"100","author":"Navarro","year":"2006","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.cpt.2025.03.004_bib70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.bjp.0706590","article-title":"Effects of the antifungal antibiotic clotrimazole on human cardiac repolarization potassium currents","volume":"147","author":"Tian","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpt.2025.03.004_bib71","doi-asserted-by":"crossref","first-page":"28032","DOI":"10.1074\/jbc.273.43.28032","article-title":"Clotrimazole, an antimycotic drug, inhibits the sarcoplasmic reticulum calcium pump and contractile function in heart muscle","volume":"273","author":"Snajdrova","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cpt.2025.03.004_bib72","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12272-009-1416-6","article-title":"Inhibitory effects of clotrimazole on TNF-\u03b1-induced adhesion molecule expression and angiogenesis","volume":"32","author":"Thapa","year":"2009","journal-title":"Arch Pharm Res (Seoul)"},{"key":"10.1016\/j.cpt.2025.03.004_bib73","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1021\/acs.cgd.3c00520","article-title":"Two novel drug\u2013drug cocrystals of antifungal clotrimazole with nonsteroidal anti-inflammatory drugs","volume":"23","author":"Drozd","year":"2023","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.cpt.2025.03.004_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.997621","article-title":"Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cpt.2025.03.004_bib75","article-title":"Clotrimazole impact on macrophage M2 polarization by disrupting the PI3K\/AKT\/mTOR pathway","volume":"696","author":"Nascimento J\u00fanior","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cpt.2025.03.004_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1198365","article-title":"Current understanding of CTLA-4: from mechanism to autoimmune diseases","volume":"14","author":"Hossen","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cpt.2025.03.004_bib77","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4062\/biomolther.2018.042","article-title":"Imidazole antifungal drugs inhibit the cell proliferation and invasion of human breast cancer cells","volume":"26","author":"Bae","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.cpt.2025.03.004_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111984","article-title":"Synergistic interaction of cpp2 coupled with thiazole derivates combined with clotrimazole and antineoplastic drugs in prostate and colon cancer cell lines","volume":"22","author":"Duarte","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2025.03.004_bib79","first-page":"3781","article-title":"Analysis of the antitumor activity of clotrimazole on A375 human melanoma cells","volume":"35","author":"Adinolfi","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cpt.2025.03.004_bib80","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1038\/sj.onc.1210308","article-title":"Blockage of intermediate-conductance-Ca2+-activated K+ channels inhibits progression of human endometrial cancer","volume":"26","author":"Wang","year":"2007","journal-title":"Oncogene"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713225000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713225000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:39:56Z","timestamp":1773873596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713225000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2949713225000345"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2025.03.004","relation":{},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clotrimazole as a new frontier: Drug repurposing and its efficacy in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}